Despite the benefit for most patients, a small number of patients still show poor outcomes after transcatheter aortic valve implantation (TAVR). This work was able to recalibrate a previously developed risk model to predict post TAVR quality of life and provide us with a potential tool to properly estimate the chances of good recovery, or<a href="https://solaci.org/en/2018/11/02/how-to-predict-post-tavr-quality-of-life-in-real-world-patients/" title="Read more" >...</a>
The last regional sessions for this year are coming full throttle! Within the framework of the 2018 Uruguayan Congress of Cardiology, SOLACI authorities alongside Uruguayan Society of Cardiology (SUC) authorities designed a broad scientific program, which includes the most up-to-date Latin American and international interventional cardiology topics and issues. Challenges in ischemic heart disease,<a href="https://solaci.org/en/2018/11/01/discover-the-scientific-program-for-the-2018-uruguay-sessions/" title="Read more" >...</a>
After more than 4 years, SOLACI returns to Montevideo to carry out the XXXVII edition of the Regional SOLACI Sessions. As always, for SOLACI it implies a great motivation and a stimulating challenge to continue promoting the development of interventional cardiology in Latin American. Are you planning on participating in the next 2018 Uruguayan Sessions?<a href="https://solaci.org/en/2018/10/31/all-you-need-to-know-about-uruguayan-sessions-2018/" title="Read more" >...</a>
Once a big void that prevented us from effectively assessing functional compromise, intermediate aortic stenosis has made us treat many lesions “just in case”, to save us what would be a complicated procedure, had a valve been placed. Auspiciously, some light has been shed by several, most welcome, studies simultaneously published in J Am Coll<a href="https://solaci.org/en/2018/10/31/ifr-assessment-of-intermediate-aortic-stenosis-lesions-consolidates/" title="Read more" >...</a>
This systematic analysis measured intracoronary pressure in different phases of the cardiac cycle and flow velocity in patients with severe aortic stenosis and coronary artery disease, who were scheduled for transcatheter aortic valve replacement (TAVR). The aim was to determine the impact of aortic stenosis on: 1) flow, at different phases; 2) hyperemic coronary flow;<a href="https://solaci.org/en/2018/10/30/what-should-we-use-for-the-functional-assessment-of-coronary-lesions-in-severe-aortic-stenosis/" title="Read more" >...</a>
Patients undergoing transcatheter aortic valve replacement (TAVR) randomized to rivaroxaban in the GALILEO trial experienced higher risk of all-cause death, thromboembolic events, and bleeding compared with patients who received antiplatelet therapy. The GALILEO trial was halted after an early peek of events at the data from the rivaroxaban (Xarelto; Bayer/Janssen) arm. These events included higher<a href="https://solaci.org/en/2018/10/26/galileo-rivaroxaban-after-tavr-stopped-due-to-early-event-rates/" title="Read more" >...</a>
Taking into account a simple 12-lead electrocardiography performed immediately after transcatheter aortic valve implantation (TAVI), removing the temporary pacemaker immediately is safe in patients without right bundle branch block who are in sinus rhythm with PR interval <240 ms and QRS interval <150 ms. In cases of atrial fibrillation, a QRS interval <140 ms also reassures the decision<a href="https://solaci.org/en/2018/10/23/immediate-electrocardiography-after-tavi-the-simplest-way-to-predict-conduction-disorders/" title="Read more" >...</a>
The incidence of arrhythmic events up to a year after implantation is high and involves almost half the patients with complete left bundle branch block following the procedure. Significant bradyarrhythmias occur in up to one-fifth of the patients, half of whom ultimately require a pacemaker. These data support the idea of a cardiac monitoring device<a href="https://solaci.org/en/2018/10/18/ambulatory-continuous-monitoring-in-patients-with-left-bundle-branch-block-after-tavi/" title="Read more" >...</a>
This analysis shows that baseline right bundle branch block and increased PR length after transcatheter aortic valve replacement (TAVR) are independent predictors of advanced conduction disturbances requiring late pacemaker implantation. A simple electrocardiography can detect these potentially fatal conduction disturbances that might happen more than 48 hours after TAVR. Data from consecutive TAVR patients from<a href="https://solaci.org/en/2018/10/18/predictors-of-conduction-disturbances-requiring-a-late-permanent-pacemaker/" title="Read more" >...</a>
As a prologue to Peru 2018 Sessions, Nurses and Technicians Sessions will be held on October 24, 2018. The event will take place at the Main Arena of the National Cardiovascular Institute (INCOR), in Lima. These sessions will be about several topics, among others, radioprotection in the cath lab, valve disease procedures, TAVR, mitral valve,<a href="https://solaci.org/en/2018/10/11/2018-peru-sessions-nurses-and-technicians-session/" title="Read more" >...</a>